The evolution and global impact of Covid-19 and Omicron: the way forward?

Abstract

Coronaviruses are a family of pathogenic viruses that including MERS, SARS, and SARS-Cov-2, and are known to cause respiratory and other illnesses in man and animals. The SARS-CoV-2 virus, responsible for the COVID-19 virus is a monopleiotropic clade of the coronavirus family first reported in Wuhan, China in December 2019 where it was found to cause a previously unreported form of viral pneumonia. The virus readily spreads by airborne microdroplet infection, and within a month of its report to the WHO in December 2019 was found in the USA and other countries and was declared a pandemic by the WHO within the first few months of its discovery and emergence. Numerous mutations of the virus with variations in infectivity and pathogenicity began to appear within the first year, including the current Delta and Omicron, both of which are more contagious than their SARS-CoV-2 progenitor strain. Omicron, while approximately five-fold more transmissible than Delta, may infect both vaccinated and unvaccinated people, and is now responsible for the majority of currently infected people but to date has resulted in only mild and non-life-threatening outcomes. Due to the greater infectivity and the mild illness attributed to the Omicron, it may be an important development in terminating the continued spread of the pandemic.

Comparative effects of Biophotonic therapies in viral and microbial illness

“…Once the adipose tissue becomes infected, it initiates the release of inflammatory cytokines including IL-6, TNF and others which can lead to a serious and an often-fatal cytokine storm. 12 Since human obesity develops via hyperplasia and hypertrophy of preadipocytes, the adipocytes once differentiated retain their cell surface receptor domains and intracellular biosynthetic functions thereafter, similar to the receptive surfaces of tissues of other organs. The increased adipose mass thus formed, especially when combined increasing BMI, glucose intolerance, and an increased visceral adipose tissue mass and additional comorbidities often including NIDDM, IT appears to reflect a proportionately greater risk of cytokine mediated COVID-19 complications.…”

“…8,10 Once receptive tissues become infected with the virus, the intracellular viral replication occurs rapidly and may spread to other receptive tissues including adipose and other tissues, while immune responses tend to lag behind the viral replicative events. 5,12 In severe cases, death may occur due to a combination of the additive impact of the virus and comorbidities, and the more advanced the individual or multiple comorbidities, the more severe magnitude of illness may occur. 8,21 Restoration of a healthy BMI in obesity is typically a gradual and often unrewarding process, and often only temporary in duration as weight regain occurs easily when therapeutic regimens are discontinued.…”

“…The complexity of the pre-existing physical and physiological biological variables is evident among most patient histories and symptoms. The Einstein Adjuvant Energy Dynamics method [12][13][14] of the present overview includes: 1). Psycho-Video Diagnostic assessment…”

“…Numerous common symptoms that have contributed to reported coronavirus patient deaths may complicate an accurate diagnosis in the absence of immunodiagnostics, and among those who have tragically succumbed, some cited Covid-19 as the direct primary cause, while for many others, the pathophysiologic sequela of Covid-19 were additive to a pre-existing comorbidity as contributing factors to the patient's demise. [10][11][12][13] Thus laboratory findings that may be common to multiple disorders, including increases in plasma availability of inflammatory cytokines now established to be common pathophysiologic entities in multiple disorders, and when present may complicate or cloud a more accurate or precise diagnosis in the absence of virus-specific serologic analysis. 13 The present Editorial is based on retrospective analysis and review of patient outcomes using biophotonics and bioelecrromagnetic therapies as a primary treatment regimen for patients with confirmed HIV, antimicrobial resistant Staphylococcus aureus, and other infectious illness in the Einstein Medical Laboratories Clinic in the Dominican Republic since year 2000.…”

Efficacy of Biophotonics as a Therapeutic Adjunct in Resolving Microbial and Viral Infectious Illnesses

“…23--25 The complete numbers of individuals confirmed to have become infected or died from the virus may never be known for sure, however due to presumed incomplete reporting and inadequate availability of reliable diagnostics in concert with strained economic and medical resources by some countries, in addition to the recognition of prolonged symptoms, now designated as a 'long covid' complication of COVID-19. 11,25,27 Of interest, multiple vaccines were developed and marketed in less than a year from the outset of their development, marking this the shortest time to develop, test and release a new vaccine in history in any nation. 10…”